Effectiveness Evaluation of the "Mosquito-Free Campus" Initiative on Dengue Fever Prevention and Control: A Cluster Randomized Controlled Trial

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age6-15
SponsorSun Yat-sen University

About this trial

The goal of this cluster randomized controlled trial is to evaluate the effect of health education interventions on the score of the knowledge, attitudes, and practices (KAP) of dengue in in primary and middle school students in the city of Guangzhou and Foshan in China.

Individuals aged 6 to 15 years who are in grades 1-9 in primary schools in Guangzhou and Foshan will be enrolled. 20 primary schools will be randomly selected, with half designated as intervention group schools and the remaining half as control group schools. The intervention group will receive a health education intervention focused on dengue prevention every semester for 6 months, while the control group will continue with their routine school health education for 6 months.

Researchers will compare the differences in the score of the KAP of dengue between the intervention and control groups after 6 months to see if health education can improve knowledge, attitudes and practices of dengue among primary and middle school students.

Eligibility criteria

Qualifiers

Primary and middle school students within the age range of 6-15 years.

The primary and middle schools are located in Yuexiu District, Baiyun District of Guangzhou city or Nanhai District of Foshan City.

The schools have the necessary infrastructure, management level and resource allocation to participate in dengue fever prevention and control.

The schools agree to implement the intervention measures during the research period.

Disqualifiers

Unwilling to participate in the project.

Participants (students or staff members) are unable to participate in the intervention or withdraw from the study due to personal reasons.

Trial design

Treatments tested in this trial

  • Health education

Treatment groups

3,940 Participants
are divided into 2 treatment groups

Locations

This trial has no locations

Sponsors and collaborators